PrEP Use Low & Discontinuation Common for Transgender Women
Low PrEP initiation (21.8%) and high discontinuation (37.5/100 person years) observed among transgender women, with reasons unrelated to HIV risk.
Read MoreMar 2, 2024
Low PrEP initiation (21.8%) and high discontinuation (37.5/100 person years) observed among transgender women, with reasons unrelated to HIV risk.
Read MoreFeb 29, 2024
1. In this cohort study, patients with uncomplicated gram-negative bacteremia who were switched...
Read MoreFeb 27, 2024
1. Elderly participants who consumed cannabis 30 minutes before driving in a simulator were found...
Read MoreFeb 26, 2024
Women in health care occupations endure a significantly higher level of stress and burnout than...
Read MoreFeb 23, 2024
1. Having a greater number of unmet social needs was associated with lower utilization of...
Read MoreFeb 17, 2024
1. In this cohort study, estimated glomerular filtration rate based on both creatinine and...
Read MoreFeb 12, 2024
GoFundMe started as a crowdfunding site for underwriting “ideas and dreams,” and, as GoFundMe’s...
Read MoreFeb 11, 2024
1. Implementation of smartphone-based walking programs in shopping malls resulted in a significant...
Read MoreFeb 10, 2024
1. In this cross-sectional study, community-dwelling adults over the age of sixty-five averaged...
Read MoreFeb 8, 2024
1. In this randomized controlled trial, the Butantan-Dengue Vaccine (Butantan-DV) was effective in...
Read MoreFeb 7, 2024
1. In this randomized controlled trial, patients experiencing symptomatic coronavirus disease 2019...
Read MoreFeb 7, 2024
1. In this cost analysis, compared to standard care, it was found that gene therapy for sickle...
Read MoreFeb 1, 2024
1. Women with non-screen detected ductal carcinoma in situ had worse outcomes for the 25 years...
Read MoreJan 23, 2024
1. In this randomized controlled trial, replacing biomass stoves with those using liquefied...
Read MoreJan 18, 2024
Various factors impact the risk for subsequent respiratory conditions among children with RSV before age 2, including prematurity and socioeconomic status.
Read MoreJan 14, 2024
1. Patients in the primaquine group reported a significant reduction in parasitemia risk at day 63...
Read MoreJan 12, 2024
Less than a quarter of patients with HCV receive direct-acting antiviral therapy within 6 months of diagnosis.
Read MoreJan 9, 2024
1. In this randomized controlled trial, doxycycline post-exposure prophylaxis (PEP) did not...
Read MoreJan 9, 2024
PClick to read the study in PLOS 1. In a Malaysian cohort of adults affected with COVID-19, 3.4%...
Read MoreJan 6, 2024
1. In this randomized-controlled trial, an mRNA-based vaccine was efficacious at preventing...
Read More